论文部分内容阅读
目的探讨心脏起搏器植入对90岁以上超高龄患者的疗效及安全性。方法连续入选38例首次接受起搏器治疗的超高龄患者,年龄(91.7±2.0)岁,分析其手术过程、术后并发症及术后一年随访结果。结果所有38例患者均成功植入心脏起搏器,其中单腔起搏器28例,双腔起搏器10例。1例患者因肾功能衰竭于术后24天死亡,其余患者术后无并发症,术后平均住院天数为(5.6±3.4)天。术后一年内有4例患者共5次住院,但均与起搏器无直接关联,无患者死亡,无患者出现黑矇、晕厥等症状。结论 90岁以上超高龄患者行永久心脏起搏器植入是有效且安全的。
Objective To investigate the efficacy and safety of cardiac pacemaker implantation in patients over 90 years of age. Methods Thirty-eight patients with ultra-advanced age who underwent the first pacemaker treatment were enrolled in the study. Their age was (91.7 ± 2.0) years old. The surgical procedure, postoperative complications and one-year postoperative follow-up were analyzed. Results All 38 patients were successfully implanted pacemakers, including 28 cases of single-chamber pacemaker and 10 cases of double-chamber pacemaker. One patient died of renal failure 24 days after operation, and the remaining patients had no postoperative complications. The average postoperative hospital stay was (5.6 ± 3.4) days. Four patients were admitted to the hospital for 5 times within a year after surgery, but none were directly related to the pacemaker. No patient died, and no symptoms such as amaurosis and fainting appeared in the patient. Conclusion Permanent cardiac pacemaker implantation in patients over 90 years of age is effective and safe.